Coronary microvascular dysfunction in post-PCI target vessels: a systematic review and meta-analysis of prevalence

Yunze Li1,2, Jinlan Duan3, Hongxu Liu2

  • 1Graduate School, Beijing University of Chinese Medicine, Beijing, China.

Abstract

Insights

Coronary microvascular dysfunction (CMD) after percutaneous coronary intervention (PCI) affects nearly 40% of patients and significantly increases the risk of major adverse cardiovascular events and cardiac death.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Coronary microvascular dysfunction (CMD) in vessels targeted by percutaneous coronary intervention (PCI) is a recognized contributor to adverse cardiovascular events.
  • The precise prevalence and prognostic impact of post-PCI CMD remain incompletely understood.

Purpose of the Study:

  • To systematically review and meta-analyze observational studies to determine the prevalence of CMD in post-PCI target vessels.
  • To assess the association between post-PCI CMD and clinical outcomes.

Main Methods:

  • A systematic literature search of PubMed, Embase, and Web of Science was conducted up to January 2025.
  • Quantitative coronary physiological assessments from 21 observational studies (6,632 patients) were analyzed using random-effects models.
  • Prevalence and multivariable-adjusted hazard ratios (HR) for clinical outcomes were calculated.

Main Results:

  • The pooled prevalence of CMD in post-PCI target vessels was 41.66%.
  • Higher CMD prevalence was observed in females, patients with acute coronary syndrome, and those assessed via non-wire-based methods.
  • CMD was independently associated with a 3.10-fold increased risk of major adverse cardiovascular events and a 4.66-fold risk of cardiac death or heart failure readmission.

Conclusions:

  • Post-PCI CMD is prevalent, affecting approximately 40% of patients.
  • CMD is an independent predictor of adverse cardiovascular outcomes, including major adverse cardiovascular events and cardiac death.
  • Standardized diagnostic criteria and targeted interventions are necessary to mitigate risks associated with post-PCI CMD.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
33
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23